Call to Action of Concerned Stakeholders on the Implementation of the EU HTA and Joint Clinical Assessment for ATMPs
ARM, along with 30+ organizations, is calling for those involved in the JCA to use all available clinical evidence, including single-arm trials and real-world evidence, to assess ATMPs, which include cell and gene therapy.
